Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Monoamine oxidase (MAO) inhibitors and uses thereof

a monoamine oxidase and inhibitor technology, applied in the field of monoamine oxidase inhibitors, can solve problems such as adverse drug-food interactions, and achieve the effect of inhibiting mao activity and increasing the concentration of monoamine compounds

Inactive Publication Date: 2005-08-11
REGENT COURT TECH
View PDF13 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0019] The compounds and substances of the present invention are capable of inhibiting MAO activity in mammalian brain and peripheral tissue. These compounds and substances act by increasing the concentration of monoamine compounds (norepinephrine, dopamine, and serotonin) in the body and brain.

Problems solved by technology

As a result, their use has been limited because hypertensive crisis may occur when certain types of food (for example, fermented foods) are ingested, thereby creating an adverse drug-food interaction.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoamine oxidase (MAO) inhibitors and uses thereof
  • Monoamine oxidase (MAO) inhibitors and uses thereof
  • Monoamine oxidase (MAO) inhibitors and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0058] Anabasine, in its purified form, was dissolved in distilled water in a maximal inhibition concentration of 0.2 mg / ml, and tested according to the procedure described above. At maximal or saturating inhibition concentrations, anabasine was effective at inhibiting MAO activity by approximately 10-13%, and was effective at inhibiting the enzyme at all time points in the reaction.

[0059]FIG. 1 presents the means (plus or minus the standard errors of the means) for the percent inhibition of MAO activity produced by saturating concentrations of anabasine over 60 minutes of MAO activity measured as described above. Each data point represented the mean of 5 determinations. All the data points shown in FIG. 1 were statistically, significantly different from the sham control at each time point tested (student t test, p<0.01), and were representative of multiple experiments.

[0060] Since anabasine was an inhibitor of MAO activity, further studies were conducted to evaluate if this agent...

example 2

[0061] Anatabine in its purified form, was dissolved in distilled water in a maximal inhibition concentration of 0.1 mg / ml, and tested according to the procedure described above. At maximal or saturating inhibition concentrations, anatabine was effective at inhibiting MAO activity by approximately 60%. This result shows that anatabine may be much safer as a medication than standard MAO enzyme inhibitors. Anatabine was effective at inhibiting the enzyme at all time points in the reaction, and was equally effective in inhibiting both MAO A and MAO B activities.

[0062]FIG. 3 presents the means (plus or minus the standard errors of the means) for the percent inhibition of MAO activity produced by saturating concentrations of anatabine over 60 minutes of MAO activity measured as described above. Each data point represented the mean of 6 determinations. Anatabine was an effective MAO inhibitor at maximal concentrations, inhibiting the enzyme by approximately 60%, as discussed above. All t...

example 3

[0064] Nornicotine in its purified form, was dissolved in distilled water in a maximal inhibition concentration of 0.08 mg / ml, and tested according to the procedure described above. At maximal or saturating inhibition concentrations, nornicotine was effective at inhibiting MAO activity by approximately 80 to 95%, and was effective at inhibiting the enzyme at all time points in the reaction. Nornicotine was also equally effective in inhibiting both MAO A and MAO B activities.

[0065]FIG. 5 presents the means (plus or minus the standard errors of the means) for the percent inhibition of MAO activity produced by saturating concentrations of nornicotine over 60 minutes of MAO activity measured as described above. Each data point represented the mean of 6 determinations. Nomicotine was an effective MAO inhibitor at maximal concentrations, inhibiting the enzyme by approximately 80-95%, as discussed above. All the data points shown in FIG. 5 were statistically, significantly different from ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
pHaaaaaaaaaa
concentration pHaaaaaaaaaa
Login to View More

Abstract

The present invention provides a group of tobacco alkaloids, tobacco extract, Yerbamaté extract, and an extract of chewing gum and lozenges which are modulators of monoamine oxidase (MAO) activity (i.e., compounds and substances which inhibit MAO enzyme and prevent its biological activity). The MAO inhibitors of the present invention can cause an increase in the level of norepinephrine, dopamine, and serotonin in the brain and other tissues, and thus can cause a wide variety of pharmacological effects mediated by their effects on these compounds. The MAO inhibitors of the present invention are useful for a variety of therapeutic applications, such as the treatment of depression, disorders of attention and focus, mood and emotional disorders, Parkinson's disease, extrapyramidal disorders, hypertension, substance abuse, smoking substitution, anti-depression therapy, eating disorders, withdrawal syndromes, and the cessation of smoking.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a division of application Ser. No. 10 / 396,319, filed Mar. 26, 2003, which is a division of application Ser. No. 10 / 042,164, filed Jan. 11, 2002, now U.S. Pat. No. 6,569,470, which is a division of application Ser. No. 09 / 325,852, filed Jun. 4, 1999, now U.S. Pat. No. 6,350,479, which claims priority under 35 U.S.C. § 119(e) to Provisional Application No. 60 / 088,117, filed Jun. 5, 1998.FIELD OF THE INVENTION [0002] The present invention relates to the novel use of compounds and substances which are capable of modulating monoamine oxidase (MAO) activity by inhibiting the MAO enzyme. The present invention also relates to MAO inhibitors and their therapeutic use as a drug or dietary supplement in the treatment of various conditions or disorders, including psychiatric and neurological illnesses. More particularly, the present invention relates to the therapeutic use of tobacco alkaloids, Yerbamaté (Ilex paraguariensis) ex...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D401/04A23F3/34A61K31/4427A61K31/4439A61K31/4545A61K36/18A61K36/185A61K36/81A61P25/00A61P25/04A61P25/14A61P25/16A61P25/22A61P25/24A61P25/28A61P25/30A61P25/34A61P43/00
CPCA23F3/34A23G4/068A23L1/3002A61K31/4439A61K36/185A61K36/81A61K2300/00A23L33/105A61P25/00A61P25/04A61P25/14A61P25/16A61P25/22A61P25/24A61P25/28A61P25/30A61P25/34A61P43/00
Inventor WILLIAMS, JONNIE R.DELORENZO, ROBERT J.BURTON, HAROLD R.
Owner REGENT COURT TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com